iShares NASDAQ Biotechnology Index (IBB) Holdings Lifted by Lucas Capital Management

Posted on: February 22, 2018 by in Blog
No Comments

iShares NASDAQ Biotechnology Index logo Lucas Capital Management boosted its holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 200.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm Continue Reading ...

Foundry Partners LLC Has $2.25 Million Position in BIO-TECHNE Corp (TECH)

Posted on: February 21, 2018 by in Blog
No Comments

BIO-TECHNE logo Foundry Partners LLC reduced its stake in shares of BIO-TECHNE Corp (NASDAQ:TECH) by 40.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,332 Continue Reading ...

At SKUAST-K, scientists use bio-technology to research on cancer treatment

Posted on: February 21, 2018 by in Blog
No Comments

Last year, a study titled “Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia” was published in Journal of Endocrinology. The study has 16 authors with Laura E Pascal, June Liu and Khalid Z Masoodi as leading Continue Reading ...

Rand Wealth LLC Buys 11524 Shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Posted on: February 21, 2018 by in Blog
No Comments

iShares NASDAQ Biotechnology Index logo Rand Wealth LLC grew its holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 181.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned Continue Reading ...

Opko Health, Inc. (OPK) vs. Nektar Therapeutics (NKTR): Comparing the Biotechnology Industry’s …

Posted on: February 20, 2018 by in Blog
No Comments

Opko Health, Inc. (NASDAQ:OPK) shares are down more than -21.43% this year and recently decreased -2.78% or -$0.11 to settle at $3.85. Nektar Therapeutics (NASDAQ:NKTR), on the other hand, is up 39.70% year to date as of 02/19/2018. It currently trades at $83.43 and has returned 11.78% Continue Reading ...

13 Charts You’ll Only Get If You Love “Stranger Things”

Posted on: February 17, 2018 by in Blog
No Comments

OK, mouth breathers. Keely Flaherty / BuzzFeed Keely Flaherty / BuzzFeed / Eggo image courtesy of Kellogg Keely Flaherty / BuzzFeed Keely Flaherty / BuzzFeed Keely Flaherty / BuzzFeed Keely Flaherty / BuzzFeed Keely Flaherty / BuzzFeed Keely Flaherty / BuzzFeed Keely Continue Reading ...

Favorable Media Coverage Somewhat Unlikely to Impact iShares NASDAQ Biotechnology Index …

Posted on: February 16, 2018 by in Blog
No Comments

iShares NASDAQ Biotechnology Index logo News articles about iShares NASDAQ Biotechnology Index (NASDAQ:IBB) have been trending positive on Friday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million Continue Reading ...

With the Correction In Pfizer Behind Us, Traders Can Go Long Again

Posted on: February 14, 2018 by in Blog
No Comments

Click to view a price quote on PFE. Click to research the Drugs Continue Reading ...

Corporate America Is Sitting on $5 Trillion of M&A Firepower

Posted on: February 13, 2018 by in Blog
No Comments

Click to view a price quote on DPS. Click to research the Food & Beverage Continue Reading ...

Immune Design Corp: Biotechnology Value Fund LP Opened Position

Posted on: February 10, 2018 by in Blog
No Comments

Investors sentiment decreased to 1.27 in Q3 2017. Its down 1.17, from 2.44 in 2017Q2. It turned negative, as 5 investors sold Immune Design Corp. shares while 21 reduced holdings. 13 funds opened positions while 20 raised stakes. 11.88 million shares or 8.39% more from 10.96 million shares Continue Reading ...